ArticleHeliyon2024
Determination of the rate and frequency of Natura 250 EW fungicide for the management of cedar rust from Gesho (
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rhamnus prinoides (Gesho) is grown in the homesteads of farmers in western Amhara. The leaves, twigs, and stems of Gesho are indispensable ingredients in traditional beverages. Its production has recently suffered from cedar rust caused by the fungus Gymnosporangium. To manage this disease, different fungicides have been recommended. Therefore, this research was designed to determine the rate and frequency of the use of the Natura 250 EW system for managing this disease in Gesho during 2020. Five application rates of Natura 250 EW and three spray frequencies were used as treatments to manage the disease in infected Gesho plants via the Randomized Complete Block Design (RCBD). Statistically significant differences (P ≤ 0.05) were found between treatments for most parameters. Among these 0.75 litter ha-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.